Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael J. Curcio
Observed names:
M Curcio,
M J Curcio,
M. Curcio,
MJ Curcio,
Michael Curcio
Observed institutions:
Memorial Sloan Kettering Cancer Center,
University of Massachusetts Chan Medical School,
Cornell University
OpenAlex ID:
A5111610177
Tumor Therapy with Targeted Atomic Nanogenerators
2001
·
Michael R. McDevitt
, Dangshe Ma
, et al.
·
Science
·
501
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
2000
·
M R McDevitt
, E Barendswaard
, et al.
·
PubMed
·
259
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
2013
·
Tao Dao
, Su Yan
, et al.
·
Science Translational Medicine
·
183
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
1999
·
T K Nikula
, M R McDevitt
, et al.
·
PubMed
·
176
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
2015
·
Tao Dao
, Dmitry Pankov
, et al.
·
Nature Biotechnology
·
164
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
2017
·
Aaron Y. Chang
, Tao Dao
, et al.
·
Journal of Clinical Investigation
·
93
PDF
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity
1995
·
Tuomo K. Nikula
, Monica Bocchia
, et al.
·
Molecular Immunology
·
86
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies
1995
·
Tuomo K. Nikula
, Michael J. Curcio
, et al.
·
Nuclear Medicine and Biology
·
67
The multidrug resistance phenotype confers immunological resistance.
1996
·
J H Weisburg
, M Curcio
, et al.
·
The Journal of Experimental Medicine
·
58
PDF
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies
2002
·
D Ma
, MR McDevitt
, et al.
·
Leukemia
·
55
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2014
·
Nicholas Veomett
, Tao Dao
, et al.
·
Clinical Cancer Research
·
50
The Effect of Centrally Administered CCK-Receptor Antagonists on Food Intake in Rats
1997
·
Michael Curcio
, James Gibbs
, et al.
·
Physiology & Behavior
·
37
Influence of the Linker on the Biodistribution and Catabolism of Actinium-225 Self-Immolative Tumor-Targeted Isotope Generators
2006
·
Christophe Antczak
, Jaspreet S. Jaggi
, et al.
·
Bioconjugate Chemistry
·
35
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
2017
·
Aaron Y. Chang
, Tao Dao
, et al.
·
Journal of Clinical Investigation
·
18
PDF
Immunoreactivity assay for -particle emitting monoclonal antibody constructs
2005
·
Anthony S. Bonavia
, Michael R. McDevitt
, et al.
·
Applied Radiation and Isotopes
·
7
A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models
2013
·
Dmitry Pankov
, Tao Dao
, et al.
·
Blood
·
5
An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments
2020
·
Martin G. Klatt
, Zita E.H. Aretz
, et al.
·
Journal of Proteomics
·
4
Alpha particle emitting constructs of recomblnant humanized antl-CD33 for myelold teukemlas
1994
·
T. K. Nikula
, R. Finn
, et al.
·
Journal of Immunotherapy
·
1
Supplementary Figure 4 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
PDF
Supplementary Figure 1 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
Supplementary Table 1 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
PDF
Supplementary Materials and Methods from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
Supplementary Figure 3 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
PDF
Supplementary Figure 2 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
PDF
Supplementary Table 1 from Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
2023
·
Nicholas Veomett
, Tao Dao
, et al.
Show more works
View as search
Works count:
34
Citation count:
1,799
H-index:
14
I10-index:
14
Year
Topic
Type
